Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Recent news of the prospectus for post Nasdaq funding and the CEO speaking of picking the 'right time'. Maybe things will be going well enough for shareholders to get 2/1 in the deal when AGN moves.
Finally moving forward now with the 'NASH deal' drug for CKD with an initial GMP contract.
Of course, expected news from the UK on the Micro-dose DMT MHRA applications for their stroke Clinical trials.

Good new interview folks should watch for themselves. JMHO...GLTA...